On Thursday analysts at Citigroup increased the price target on healthcare company Allergan, Inc. (AGN) citing continuous double digit growth in its core businesses.
The analysts back a “Buy” rating on AGN and now see shares reaching $124. This target suggests a 14% upside to Wednesday’s closing price of $108.53.
Allergan shares were down $1.44, or -1.36%, during morning trading on Thursday. The stock is up about 23% over the past year.
The Bottom Line
Shares of Allergan (AGN) have a dividend yield of 0.19% based on Thursday’s intraday trading price of $107.37 and the company’s annualized dividend payout of 20 cents per share.
Allergan, Inc. (AGN) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.